ARMO BIOSCIENCES INC (ARMO) Stock Price & Overview
NASDAQ:ARMO • US04225U1043
Current stock price
The current stock price of ARMO is 49.98 null. Today ARMO is up by 0.02%. In the past month the price increased by 0.16%.
ARMO Key Statistics
- Market Cap
- 1.52B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -28.52
- Dividend Yield
- N/A
ARMO Stock Performance
ARMO Stock Chart
ARMO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ARMO.
ARMO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ARMO. ARMO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ARMO Earnings
ARMO Forecast & Estimates
ARMO Financial Highlights
Over the last trailing twelve months ARMO reported a non-GAAP Earnings per Share(EPS) of -28.52. The EPS decreased by -8.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.23% | ||
| ROE | -27.05% | ||
| Debt/Equity | 0 |
ARMO Ownership
About ARMO
Company Profile
ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating effects which induce the activation, proliferation and survival of intratumoral, tumor-reactive, cytotoxic CD8 T cells in cancer patients. Its product pipeline includes AM0001, an anti-PD-1 checkpoint inhibitor; AM0003 an anti-LAG-3 checkpoint inhibitor; AM0015 a form of recombinant human Interleukin-15 cytokine and AM0012 a form of recombinant human Interleukin-12 cytokine. ARMO Biosciences, Inc. is based in REDWOOD CITY, United States.
Company Info
ARMO BIOSCIENCES INC
575 Chesapeake Drive
Redwood City CA 94063
CEO: Peter Van Vlasselaer
Phone: 650-779-5075
ARMO BIOSCIENCES INC / ARMO FAQ
What does ARMO do?
ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating effects which induce the activation, proliferation and survival of intratumoral, tumor-reactive, cytotoxic CD8 T cells in cancer patients. Its product pipeline includes AM0001, an anti-PD-1 checkpoint inhibitor; AM0003 an anti-LAG-3 checkpoint inhibitor; AM0015 a form of recombinant human Interleukin-15 cytokine and AM0012 a form of recombinant human Interleukin-12 cytokine. ARMO Biosciences, Inc. is based in REDWOOD CITY, United States.
What is the stock price of ARMO BIOSCIENCES INC today?
The current stock price of ARMO is 49.98 null. The price increased by 0.02% in the last trading session.
Does ARMO BIOSCIENCES INC pay dividends?
ARMO does not pay a dividend.
What is the ChartMill technical and fundamental rating of ARMO stock?
ARMO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is ARMO stock listed?
ARMO stock is listed on the Nasdaq exchange.